Logo image of BCAL

CALIFORNIA BANCORP (BCAL) Stock Fundamental Analysis

USA - NASDAQ:BCAL - US84252A1060 - Common Stock

18.27 USD
-0.01 (-0.05%)
Last: 11/19/2025, 2:58:11 PM
Fundamental Rating

5

Overall BCAL gets a fundamental rating of 5 out of 10. We evaluated BCAL against 388 industry peers in the Banks industry. While BCAL is still in line with the averages on profitability rating, there are concerns on its financial health. BCAL is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BCAL had positive earnings in the past year.
In the past year BCAL had a positive cash flow from operations.
BCAL Yearly Net Income VS EBIT VS OCF VS FCFBCAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

BCAL's Return On Assets of 0.79% is in line compared to the rest of the industry. BCAL outperforms 42.53% of its industry peers.
BCAL has a worse Return On Equity (5.71%) than 72.68% of its industry peers.
BCAL has a better Return On Invested Capital (2.17%) than 99.48% of its industry peers.
BCAL had an Average Return On Invested Capital over the past 3 years of 1.52%. This is in line with the industry average of 2.55%.
The 3 year average ROIC (1.52%) for BCAL is below the current ROIC(2.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.79%
ROE 5.71%
ROIC 2.17%
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.52%
ROIC(5y)N/A
BCAL Yearly ROA, ROE, ROICBCAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6 8

1.3 Margins

With a Profit Margin value of 13.66%, BCAL is not doing good in the industry: 80.15% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of BCAL has declined.
BCAL has a Operating Margin of 54.68%. This is amongst the best in the industry. BCAL outperforms 99.74% of its industry peers.
In the last couple of years the Operating Margin of BCAL has grown nicely.
Industry RankSector Rank
OM 54.68%
PM (TTM) 13.66%
GM N/A
OM growth 3Y19.95%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCAL Yearly Profit, Operating, Gross MarginsBCAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BCAL is destroying value.
The number of shares outstanding for BCAL has been increased compared to 1 year ago.
BCAL has a better debt/assets ratio than last year.
BCAL Yearly Shares OutstandingBCAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
BCAL Yearly Total Debt VS Total AssetsBCAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

BCAL has an Altman-Z score of -0.68. This is a bad value and indicates that BCAL is not financially healthy and even has some risk of bankruptcy.
BCAL has a Altman-Z score of -0.68. This is amongst the best in the industry. BCAL outperforms 98.97% of its industry peers.
BCAL has a debt to FCF ratio of 54.39. This is a negative value and a sign of low solvency as BCAL would need 54.39 years to pay back of all of its debts.
BCAL's Debt to FCF ratio of 54.39 is on the low side compared to the rest of the industry. BCAL is outperformed by 84.54% of its industry peers.
BCAL has a Debt/Equity ratio of 6.15. This is a high value indicating a heavy dependency on external financing.
BCAL has a worse Debt to Equity ratio (6.15) than 96.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.15
Debt/FCF 54.39
Altman-Z -0.68
ROIC/WACC0.57
WACC3.84%
BCAL Yearly LT Debt VS Equity VS FCFBCAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

BCAL has a Current Ratio of 0.04. This is a bad value and indicates that BCAL is not financially healthy enough and could expect problems in meeting its short term obligations.
BCAL has a Current ratio of 0.04. This is amongst the best in the industry. BCAL outperforms 99.23% of its industry peers.
A Quick Ratio of 0.04 indicates that BCAL may have some problems paying its short term obligations.
The Quick ratio of BCAL (0.04) is better than 99.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
BCAL Yearly Current Assets VS Current LiabilitesBCAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B

8

3. Growth

3.1 Past

BCAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 321.74%, which is quite impressive.
BCAL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.36% yearly.
Looking at the last year, BCAL shows a very strong growth in Revenue. The Revenue has grown by 55.36%.
BCAL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.61% yearly.
EPS 1Y (TTM)321.74%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%1060%
Revenue 1Y (TTM)55.36%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%18.54%

3.2 Future

The Earnings Per Share is expected to grow by 36.38% on average over the next years. This is a very strong growth
Based on estimates for the next years, BCAL will show a quite strong growth in Revenue. The Revenue will grow by 13.74% on average per year.
EPS Next Y158.03%
EPS Next 2Y55.97%
EPS Next 3Y36.38%
EPS Next 5YN/A
Revenue Next Year38.02%
Revenue Next 2Y19.11%
Revenue Next 3Y13.74%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BCAL Yearly Revenue VS EstimatesBCAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
BCAL Yearly EPS VS EstimatesBCAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.42, which indicates a very decent valuation of BCAL.
76.80% of the companies in the same industry are more expensive than BCAL, based on the Price/Earnings ratio.
BCAL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.46.
A Price/Forward Earnings ratio of 10.29 indicates a reasonable valuation of BCAL.
BCAL's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of BCAL to the average of the S&P500 Index (35.39), we can say BCAL is valued rather cheaply.
Industry RankSector Rank
PE 9.42
Fwd PE 10.29
BCAL Price Earnings VS Forward Price EarningsBCAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

99.48% of the companies in the same industry are more expensive than BCAL, based on the Enterprise Value to EBITDA ratio.
65.46% of the companies in the same industry are more expensive than BCAL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.6
EV/EBITDA 4.31
BCAL Per share dataBCAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BCAL's earnings are expected to grow with 36.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y55.97%
EPS Next 3Y36.38%

0

5. Dividend

5.1 Amount

BCAL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CALIFORNIA BANCORP

NASDAQ:BCAL (11/19/2025, 2:58:11 PM)

18.27

-0.01 (-0.05%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)01-27 2026-01-27/bmo
Inst Owners57.67%
Inst Owner Change1.02%
Ins Owners24.1%
Ins Owner Change0.14%
Market Cap594.14M
Revenue(TTM)231.84M
Net Income(TTM)31.26M
Analysts84.44
Price Target19.38 (6.08%)
Short Float %1.53%
Short Ratio2.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.56%
Min EPS beat(2)3.66%
Max EPS beat(2)27.45%
EPS beat(4)4
Avg EPS beat(4)33.05%
Min EPS beat(4)3.66%
Max EPS beat(4)87.43%
EPS beat(8)4
Avg EPS beat(8)0.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)-2.03%
Revenue beat(4)0
Avg Revenue beat(4)-4.17%
Min Revenue beat(4)-8.89%
Max Revenue beat(4)-2.03%
Revenue beat(8)0
Avg Revenue beat(8)-4.74%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.79%
PT rev (3m)1.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)6.83%
EPS NY rev (3m)6.93%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)-0.05%
Revenue NY rev (1m)0.84%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 9.42
Fwd PE 10.29
P/S 2.6
P/FCF 9.6
P/OCF 9.53
P/B 1.09
P/tB 1.43
EV/EBITDA 4.31
EPS(TTM)1.94
EY10.62%
EPS(NY)1.78
Fwd EY9.72%
FCF(TTM)1.9
FCFY10.41%
OCF(TTM)1.92
OCFY10.49%
SpS7.04
BVpS16.84
TBVpS12.8
PEG (NY)0.06
PEG (5Y)N/A
Graham Number27.11
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 5.71%
ROCE 20.83%
ROIC 2.17%
ROICexc 2.22%
ROICexgc 2.34%
OM 54.68%
PM (TTM) 13.66%
GM N/A
FCFM 27.04%
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.52%
ROIC(5y)N/A
ROICexc(3y)1.54%
ROICexc(5y)N/A
ROICexgc(3y)1.61%
ROICexgc(5y)N/A
ROCE(3y)15.77%
ROCE(5y)N/A
ROICexgc growth 3Y37.36%
ROICexgc growth 5YN/A
ROICexc growth 3Y36.52%
ROICexc growth 5YN/A
OM growth 3Y19.95%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 6.15
Debt/FCF 54.39
Debt/EBITDA 25.73
Cap/Depr 8.18%
Cap/Sales 0.2%
Interest Coverage 2.01
Cash Conversion 47.67%
Profit Quality 197.92%
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -0.68
F-Score8
WACC3.84%
ROIC/WACC0.57
Cap/Depr(3y)28.31%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.57%
Cap/Sales(5y)N/A
Profit Quality(3y)372.76%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)321.74%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%1060%
EPS Next Y158.03%
EPS Next 2Y55.97%
EPS Next 3Y36.38%
EPS Next 5YN/A
Revenue 1Y (TTM)55.36%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%18.54%
Revenue Next Year38.02%
Revenue Next 2Y19.11%
Revenue Next 3Y13.74%
Revenue Next 5YN/A
EBIT growth 1Y81.16%
EBIT growth 3Y65.06%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.29%
FCF growth 3Y40.59%
FCF growth 5YN/A
OCF growth 1Y59.14%
OCF growth 3Y36.79%
OCF growth 5YN/A

CALIFORNIA BANCORP / BCAL FAQ

Can you provide the ChartMill fundamental rating for CALIFORNIA BANCORP?

ChartMill assigns a fundamental rating of 5 / 10 to BCAL.


Can you provide the valuation status for CALIFORNIA BANCORP?

ChartMill assigns a valuation rating of 7 / 10 to CALIFORNIA BANCORP (BCAL). This can be considered as Undervalued.


Can you provide the profitability details for CALIFORNIA BANCORP?

CALIFORNIA BANCORP (BCAL) has a profitability rating of 4 / 10.


What is the valuation of CALIFORNIA BANCORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CALIFORNIA BANCORP (BCAL) is 9.42 and the Price/Book (PB) ratio is 1.09.